Orphan Drugs Market

Orphan Drugs Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

215

Base Year:

2023

Dec - 2024

Format:

Report Code:

VMR-VMR-2021-0236

Segments Covered

By Therapy Type Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, Infectious Diseases, Others
By Drug Type Biologics, Non-biologics
By Distribution Channel Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 177 Billion
Revenue 2032:	USD 505 Billion
Revenue CAGR (2024 - 2032):	12.4%
Fastest Growing Region (2024 - 2032)	Europe
Largest Region (2023):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Orphan Drugs Market - Segment Analysis
1. Overview
2. Global Orphan Drugs Market, 2016 - 2028 (USD Million)
3. Global Orphan Drugs Market - by Therapy Type
  1. By Oncology
  2. By Hematology
  3. By Neurology
  4. By Endocrinology
  5. By Cardiovascular
  6. By Respiratory
  7. By Immunotherapy
  8. By Infectious Diseases
  9. By Others
4. Global Orphan Drugs Market - by Drug Type
  1. By Biologics
  2. By Non-biologics
5. Global Orphan Drugs Market - by Distribution Channel
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
  4. By Others
6. Global Orphan Drugs Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Orphan Drugs Market - Segment Analysis
1. Overview
2. North America Orphan Drugs Market, 2016 - 2028 (USD Million)
3. North America Orphan Drugs Market, by Therapy Type
  1. By Oncology
  2. By Hematology
  3. By Neurology
  4. By Endocrinology
  5. By Cardiovascular
  6. By Respiratory
  7. By Immunotherapy
  8. By Infectious Diseases
  9. By Others
4. North America Orphan Drugs Market, by Drug Type
  1. By Biologics
  2. By Non-biologics
5. North America Orphan Drugs Market, by Distribution Channel
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
  4. By Others
6. North America Orphan Drugs Market, by Country
  1. U.S.
    1. U.S. Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. U.S. Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. U.S. Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  2. Canada
    1. Canada Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Canada Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Canada Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  3. Mexico
    1. Mexico Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Mexico Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Mexico Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
Europe Orphan Drugs Market - Segment Analysis
1. Overview
2. Europe Orphan Drugs Market, 2016 - 2028 (USD Million)
3. Europe Orphan Drugs Market, by Therapy Type
  1. By Oncology
  2. By Hematology
  3. By Neurology
  4. By Endocrinology
  5. By Cardiovascular
  6. By Respiratory
  7. By Immunotherapy
  8. By Infectious Diseases
  9. By Others
4. Europe Orphan Drugs Market, by Drug Type
  1. By Biologics
  2. By Non-biologics
5. Europe Orphan Drugs Market, by Distribution Channel
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
  4. By Others
6. Europe Orphan Drugs Market, by Country
  1. Germany
    1. Germany Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Germany Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Germany Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  2. UK
    1. UK Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. UK Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. UK Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  3. France
    1. France Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. France Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. France Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  4. Spain
    1. Spain Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Spain Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Spain Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  5. Italy
    1. Italy Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Italy Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Italy Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  6. BENELUX
    1. BENELUX Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. BENELUX Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. BENELUX Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  7. Rest of Europe
    1. Rest Of Europe Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Rest Of Europe Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Rest Of Europe Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
Asia Pacific Orphan Drugs Market - Segment Analysis
1. Overview
2. Asia Pacific Orphan Drugs Market, 2016 - 2028 (USD Million)
3. Asia Pacific Orphan Drugs Market, by Therapy Type
  1. By Oncology
  2. By Hematology
  3. By Neurology
  4. By Endocrinology
  5. By Cardiovascular
  6. By Respiratory
  7. By Immunotherapy
  8. By Infectious Diseases
  9. By Others
4. Asia Pacific Orphan Drugs Market, by Drug Type
  1. By Biologics
  2. By Non-biologics
5. Asia Pacific Orphan Drugs Market, by Distribution Channel
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
  4. By Others
6. Asia Pacific Orphan Drugs Market, by Country
  1. China
    1. China Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. China Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. China Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  2. Japan
    1. Japan Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Japan Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Japan Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  3. India
    1. India Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. India Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. India Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  4. South Korea
    1. South Korea Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. South Korea Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. South Korea Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  5. South East Asia
    1. South East Asia Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. South East Asia Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. South East Asia Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Rest of Asia Pacific Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Rest of Asia Pacific Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
Latin America Orphan Drugs Market - Segment Analysis
1. Overview
2. Latin America Orphan Drugs Market, 2016 - 2028 (USD Million)
3. Latin America Orphan Drugs Market, by Therapy Type
  1. By Oncology
  2. By Hematology
  3. By Neurology
  4. By Endocrinology
  5. By Cardiovascular
  6. By Respiratory
  7. By Immunotherapy
  8. By Infectious Diseases
  9. By Others
4. Latin America Orphan Drugs Market, by Drug Type
  1. By Biologics
  2. By Non-biologics
5. Latin America Orphan Drugs Market, by Distribution Channel
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
  4. By Others
6. Latin America Orphan Drugs Market, by Country
  1. Brazil
    1. Brazil Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Brazil Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Brazil Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  2. Argentina
    1. Argentina Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Argentina Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Argentina Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  3. Rest of Latin America
    1. Rest of Latin America Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Rest of Latin America Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Rest of Latin America Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
Middle East & Africa Orphan Drugs Market - Segment Analysis
1. Overview
2. Middle East & Africa Orphan Drugs Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Orphan Drugs Market, by Therapy Type
  1. By Oncology
  2. By Hematology
  3. By Neurology
  4. By Endocrinology
  5. By Cardiovascular
  6. By Respiratory
  7. By Immunotherapy
  8. By Infectious Diseases
  9. By Others
4. Middle East & Africa Orphan Drugs Market, by Drug Type
  1. By Biologics
  2. By Non-biologics
5. Middle East & Africa Orphan Drugs Market, by Distribution Channel
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
  4. By Others
6. Middle East & Africa Orphan Drugs Market, by Country
  1. GCC Countries
    1. GCC Countries Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. GCC Countries Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. GCC Countries Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  2. South Africa
    1. South Africa Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. South Africa Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. South Africa Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Orphan Drugs Market, By Therapy Type
      1. By Oncology
      2. By Hematology
      3. By Neurology
      4. By Endocrinology
      5. By Cardiovascular
      6. By Respiratory
      7. By Immunotherapy
      8. By Infectious Diseases
      9. By Others
    2. Rest of Middle East & Africa Orphan Drugs Market, By Drug Type
      1. By Biologics
      2. By Non-biologics
    3. Rest of Middle East & Africa Orphan Drugs Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
      4. By Others
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. F. Hoffmann-La Roche Ltd.
2. Bristol-Myers Squibb Company
3. Johnson & Johnson
4. AstraZeneca
5. Novartis AG
6. Amgen Inc.
7. Bayer AG
8. Novo Nordisk A/S
9. Daiichi Sankyo Company
10. GlaxoSmithKline plc
11. Alexion Pharmaceuticals Inc.
12. Biogen Inc.
13. Pfizer Inc.
14. Sanofi S.A.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Orphan Drugs in terms of revenue?

The global Orphan Drugs valued at USD 177 Billion in 2023 and is expected to reach USD 505 Billion in 2032 growing at a CAGR of 12.4%.

Which are the prominent players in the market?

The prominent players in the market are F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Johnson & Johnson, AstraZeneca, Novartis AG, Amgen Inc., Bayer AG, Novo Nordisk A/S, Daiichi Sankyo Company, GlaxoSmithKline plc, Alexion Pharmaceuticals Inc., Biogen Inc., Pfizer Inc., Sanofi S.A..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 12.4% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Orphan Drugs include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Orphan Drugs in 2023.

Orphan Drugs Market

Orphan Drugs Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Orphan Drugs in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Orphan Drugs Market

Orphan Drugs Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Orphan Drugs in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Orphan Drugs Market

Vantage Point Interactive Dashboard